Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000950170-24-118473
Filing Date
2024-10-29
Accepted
2024-10-29 20:18:53
Documents
2
Period of Report
2024-10-25

Document Format Files

Seq Description Document Type Size
1 3 ownership.html 3  
1 3 ownership.xml 3 14450
2 EX-24 aura-ex24.htm EX-24 16039
  Complete submission text file 0000950170-24-118473.txt   31900
Mailing Address 80 GUEST STREET BOSTON MA 02135
Business Address 80 GUEST STREET BOSTON MA 02135 (617)500-8864
Aura Biosciences, Inc. (Issuer) CIK: 0001501796 (see all company filings)

EIN.: 320271970 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address C/O AURA BIOSCIENCES, INC. 80 GUEST STREET BOSTON MA 01235
Business Address
Elazzouzi Amy (Reporting) CIK: 0002042910 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-40971 | Film No.: 241407110